|Assessment Status||Rapid Review Complete|
|Indication||Chlormethine gel (Ledaga®) is indicated for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL) in adult patients.|
|Rapid review commissioned||31/07/2023|
|Rapid review completed||20/09/2023|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that chlormethine gel not be considered for reimbursement at the submitted price*.|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.